Emergence of India as a Global Manufacturing Hub for Biosimilars: The biopharmaceutical landscape of India is transforming in terms of regulatory policies, product development, and affordability

Bibliographische Detailangaben

Veröffentlicht in:	Biopharm international 2021-11, Vol.34 (11), p.42
Hauptverfasser:	Rathore, Anurag S, Joshi, Srishti, Dash, Rozaleen, Nupur, Neh, Sreenivasan, Shravan
Format:	Magazinearticle
Sprache:	eng
Schlagworte:	Biological products industry Biosimilar pharmaceuticals Growth Laws, regulations and rules Quality management Safety and security measures
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!